EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS134-02634 
Organism
Homo sapiens 
Tissue/cell
Mesendoderm 
Coordinate
chr1:101087600-101088420 
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
MSCMA0665.1chr1:101088279-101088289AACAGCTGTT+6.02
MSCMA0665.1chr1:101088279-101088289AACAGCTGTT-6.02
MYF6MA0667.1chr1:101088279-101088289AACAGCTGTT+6.02
MYF6MA0667.1chr1:101088279-101088289AACAGCTGTT-6.02
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_45780chr1:101086339-101097802Osteoblasts
SE_51929chr1:101086746-101091215Skeletal_Muscle_Myoblast
SE_55943chr1:101085569-101097753u87
SE_63727chr1:101086919-101091372HSMM
SE_67718chr1:101085569-101097753u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1101088225101088325
Number: 1             
IDChromosomeStartEnd
GH01I100621chr1101086920101091298
Enhancer Sequence
TTTGCTGTTT ATATTGTTTT CTTTCCTTCT CAAATCAACA TGAGTTGTAC AGACCATAAT 60
AAAAGCTTCA TCTTGAGCCT GTTATTGCAT CACCATTTGG CTGATGTTTC ACTGCTCCAT 120
CACTGTGGGA GGTTAACACT CACTGAGGGG TGGCAGTACC CTCTGCATTT CTCTGGGAAA 180
CTCCAATGAT TCATCCAAAA GTGTGAGAAG CCAAGCAGCT TTTATCACCC AGGAGACAGC 240
TGTAACCTGA CCTCAATTCA TGCCAAAGAA GCCTGAGGAA AGTGCCCTGG AAGTGAACAG 300
CCTGCTCATG ACTCAAGGAA CTCAAAAGTC AGAGTTCTGA CCAGTATTGT TGGGGTGGGT 360
AAAAGAACTT CACTCCCTCA GATCTGAAAG TGTCCTTGCC AGAGGAGAGG GAGACCTTAT 420
TTCAAGTGTG TTTGAATAAA CATGACATAC ATAAACTTGA TTTTCCAGGT TTTGGAGAAA 480
GCATACATTT GTCCTCTGCA TCATGAAATA ATGTCCTTGG TGGCTCCTTT CAGGGCCTGT 540
GCTGCACTCT CCTTAGTGAC TATTAGCATT GGAGTTGGAC AATTTAAGGG CAGGAGTGGA 600
GACCTGCTAC TTATAAAGGA TGACTACACT TATTTAGGGA TACTGCTCAC GCTGACTCTC 660
AGAGCAATTC TTTTGTTCCA ACAGCTGTTC CCAGGGTAGG GTAATATTGG AACAGAGGCT 720
TATGCTGCAG TATCCATTGA GTGGGACTGA GGCCCCTTCA GTAGCTGAAA ATCCCCACTT 780
CAGTGCTACT GCTTCAGCTA CTGCAGCTCT TACTGTCTTC 820